Margaret Stefater-Richards, MD, PhD
Medical Director, EMPOWER Program; Attending Physician, Division of Endocrinology
Assistant Professor, Harvard Medical School
Image
Margaret Stefater-Richards, MD, PhD
Medical Director, EMPOWER Program; Attending Physician, Division of Endocrinology
Assistant Professor, Harvard Medical School
Medical Services
Languages
English
Education
Undergraduate School
Northwestern University ,
2005
Evanston
IL
Graduate School
University of Cincinnati
2010
Cincinnati
OH
Medical School
University of Cincinnati
2012
Cincinnati
OH
Internship
Pediatrics
Boston Combined Residency Program (BCRP)
2013
Boston
MA
Residency
Pediatrics
Boston Combined Residency Program (BCRP)
2015
Boston
MA
Fellowship
Pediatric Endocrinology
Boston Children's Hospital
2018
Boston
MA
Media
Parentcast Podcast
Dr. Margeret Stefater- is featured: Is weight loss medication an option for my teen?
Certifications
American Board of Pediatrics (General)
American Board of Pediatrics (Endocrinology)
American Board of Obesity Medicine
Publications
GLP-1 Receptor Agonists in Pediatric and Adolescent Obesity. View Abstract
Gastric bypass elicits persistent gut adaptation and unique diabetes remission-related metabolic gene regulation. View Abstract
The enteroendocrine axis and its effect on gastrointestinal function, nutrition, and inflammation. View Abstract
Gut adaptation after gastric bypass in humans reveals metabolically significant shift in fuel metabolism. View Abstract
Gastric Bypass in an Adolescent with Obesity, Insulin Resistance, and Type 1 Diabetes. View Abstract
Effect of Diet versus Gastric Bypass on Metabolic Function in Diabetes. View Abstract
Portal Venous Metabolite Profiling After RYGB in Male Rats Highlights Changes in Gut-Liver Axis. View Abstract
Differential Metabolomic Signatures in Patients with Weight Regain and Sustained Weight Loss After Gastric Bypass Surgery: A Pilot Study. View Abstract
Comment on: GLP-1 and PYY3-36 reduce high-fat food preference additively after Roux-en-Y gastric bypass in diet-induced obese rats. View Abstract
Glycogen storage disease presenting as Cushing syndrome. View Abstract
The Feasibility of Examining the Effects of Gastric Bypass Surgery on Intestinal Metabolism: Prospective, Longitudinal Mechanistic Clinical Trial. View Abstract
Publisher Correction: Inactivating hepatic follistatin alleviates hyperglycemia. View Abstract
Inactivating hepatic follistatin alleviates hyperglycemia. View Abstract
Bariatric Surgery for Adolescents with Type 2 Diabetes: an Emerging Therapeutic Strategy. View Abstract
A case report of methadone-associated hypoglycemia in an 11-month-old male. View Abstract
Three-decade metabolic outcome of neonatal gastrectomy and early Roux-en-Y. View Abstract
The anorectic effect of GLP-1 in rats is nutrient dependent. View Abstract
Advances in the surgical treatment of morbid obesity. View Abstract
Bariatric surgery for adolescents. View Abstract
All bariatric surgeries are not created equal: insights from mechanistic comparisons. View Abstract
The anorectic effect of CNTF does not require action in leptin-responsive neurons. View Abstract
The effect of vertical sleeve gastrectomy on food choice in rats. View Abstract
Molecular insights from bariatric surgery. View Abstract
Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats. View Abstract
Similar effects of roux-en-Y gastric bypass and vertical sleeve gastrectomy on glucose regulation in rats. View Abstract
Sleeve gastrectomy in rats improves postprandial lipid clearance by reducing intestinal triglyceride secretion. View Abstract
Central nervous system nutrient signaling: the regulation of energy balance and the future of dietary therapies. View Abstract
Sleeve gastrectomy induces loss of weight and fat mass in obese rats, but does not affect leptin sensitivity. View Abstract